These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 12825946

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. 2,3-Dihydro-5-hydroxy-2,2-dipentyl-4,6-di-tert-butylbenzofuran: design and evaluation as a novel radical-scavenging antioxidant against lipid peroxidation.
    Noguchi N, Iwaki Y, Takahashi M, Komuro E, Kato Y, Tamura K, Cynshi O, Kodama T, Niki E.
    Arch Biochem Biophys; 1997 Jun 15; 342(2):236-43. PubMed ID: 9186484
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of plasma lipid peroxidation by anti-atherogenic antioxidant BO-653, 2,3-dihydro-5-hydroxy-4,6-di-tert-butyl-2,2-dipentylbenzofuran.
    Itoh N, Yoshida Y, Hayakawa M, Noguchi N, Kodama T, Cynshi O, Niki E.
    Biochem Pharmacol; 2004 Sep 01; 68(5):813-8. PubMed ID: 15294444
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of oxidation of low-density lipoprotein by a novel antioxidant, BO-653, prepared by theoretical design.
    Noguchi N, Okimoto Y, Tsuchiya J, Cynshi O, Kodama T, Niki E.
    Arch Biochem Biophys; 1997 Nov 01; 347(1):141-7. PubMed ID: 9344475
    [Abstract] [Full Text] [Related]

  • 6. Characterization of the oxidation products of BO-653 formed during peroxyl radical-mediated oxidation of human plasma.
    Yamauchi R, Southwell-Keely P, Suarna C, Ray S, Raftery M, Cynshi O, Stocker R.
    Free Radic Biol Med; 2005 Jan 01; 38(1):32-40. PubMed ID: 15589369
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antioxidant effects of 2,3-dihydro-5-hydroxy-4,6-di-tert-butyl-2,2-dipentylbenzofuran and alpha-tocopherol in hyperlipidemic mice as evaluated by hydroxyoctadecadienoic acid and 7-hydroxycholesterol.
    Yoshida Y, Hayakawa M, Itoh N, Habuchi Y, Inoue R, Chen ZH, Cao J, Cynshi O, Jishage K, Niki E.
    Biochem Pharmacol; 2007 Oct 01; 74(7):1010-9. PubMed ID: 17706610
    [Abstract] [Full Text] [Related]

  • 11. Antioxidant action of 2,2,4,6-tetra-substituted 2,3-dihydro-5-hydroxybenzofuran against lipid peroxidation: effects of substituents and side chain.
    Yoshida Y, Noguchi N, Watanabe A, Iwaki Y, Yanagisawa M, Kodama T, Cynshi O, Niki E.
    Free Radic Res; 2002 Nov 01; 36(11):1171-8. PubMed ID: 12592669
    [Abstract] [Full Text] [Related]

  • 12. Novel low-density lipoprotein (LDL) oxidation model: antioxidant capacity for the inhibition of LDL oxidation.
    Chu YF, Liu RH.
    J Agric Food Chem; 2004 Nov 03; 52(22):6818-23. PubMed ID: 15506821
    [Abstract] [Full Text] [Related]

  • 13. Novel calcium antagonists with both calcium overload inhibition and antioxidant activity. 1. 2-(3, 5-di-tert-butyl-4-hydroxyphenyl)-3-(aminopropyl)thiazolidinones.
    Kato T, Ozaki T, Tamura K, Suzuki Y, Akima M, Ohi N.
    J Med Chem; 1998 Oct 22; 41(22):4309-16. PubMed ID: 9784106
    [Abstract] [Full Text] [Related]

  • 14. Lipoprotein oxidation: mechanistic aspects, methodological approaches and clinical relevance.
    Stocker R.
    Curr Opin Lipidol; 1994 Dec 22; 5(6):422-33. PubMed ID: 7712047
    [Abstract] [Full Text] [Related]

  • 15. Paradoxical actions of antioxidants in the oxidation of low density lipoprotein by peroxidases.
    Santanam N, Parthasarathy S.
    J Clin Invest; 1995 Jun 22; 95(6):2594-600. PubMed ID: 7769102
    [Abstract] [Full Text] [Related]

  • 16. Novel 3,5-diaryl pyrazolines and pyrazole as low-density lipoprotein (LDL) oxidation inhibitor.
    Jeong TS, Kim KS, Kim JR, Cho KH, Lee S, Lee WS.
    Bioorg Med Chem Lett; 2004 Jun 07; 14(11):2719-23. PubMed ID: 15125921
    [Abstract] [Full Text] [Related]

  • 17. Antioxidants suppress plasma levels of lectinlike oxidized low-density lipoprotein receptor-ligands and reduce atherosclerosis in watanabe heritable hyperlipidemic rabbits.
    Oka K, Yasuhara M, Suzumura K, Tanaka K, Sawamura T.
    J Cardiovasc Pharmacol; 2006 Oct 07; 48(4):177-83. PubMed ID: 17086097
    [Abstract] [Full Text] [Related]

  • 18. N,N'-diacetyl-L-cystine (DiNAC), the disulphide dimer of N-acetylcysteine, inhibits atherosclerosis in WHHL rabbits: evidence for immunomodulatory agents as a new approach to prevent atherosclerosis.
    Wågberg M, Jansson AH, Westerlund C, Ostlund-Lindqvist AM, Särnstrand B, Bergstrand H, Pettersson K.
    J Pharmacol Exp Ther; 2001 Oct 07; 299(1):76-82. PubMed ID: 11561065
    [Abstract] [Full Text] [Related]

  • 19. Development of novel antiatherogenic biaryls: design, synthesis, and reactivity.
    Delomenède M, Bedos-Belval F, Duran H, Vindis C, Baltas M, Nègre-Salvayre A.
    J Med Chem; 2008 Jun 12; 51(11):3171-81. PubMed ID: 18465848
    [Abstract] [Full Text] [Related]

  • 20. Anthocyanins increase low-density lipoprotein and plasma cholesterol and do not reduce atherosclerosis in Watanabe Heritable Hyperlipidemic rabbits.
    Finné Nielsen IL, Elbøl Rasmussen S, Mortensen A, Ravn-Haren G, Ma HP, Knuthsen P, Hansen BF, McPhail D, Freese R, Breinholt V, Frandsen H, Dragsted LO.
    Mol Nutr Food Res; 2005 Apr 12; 49(4):301-8. PubMed ID: 15759306
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.